{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Earth City",
      "address_1": "13600 Shoreline Dr",
      "reason_for_recall": "Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.",
      "address_2": "",
      "product_quantity": "111,384 sample packs",
      "code_info": "Lot  1112467 Exp. 02/15",
      "center_classification_date": "20140204",
      "distribution_pattern": "Nationwide and Puerto Rico.",
      "state": "MO",
      "product_description": "Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only,  Forest Pharmaceuticals Inc., St. Louis, MO 63045  NDC 0456-3428-05.",
      "report_date": "20140212",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Forest Pharmaceuticals Inc",
      "recall_number": "D-1065-2014",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "66838",
      "termination_date": "20140507",
      "more_code_info": "",
      "recall_initiation_date": "20131113",
      "postal_code": "63045",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}